Noninvasive assisted pressure-controlled ventilation: As effective as pressure support ventilation in chronic obstructive pulmonary disease?


Kirakli C., Cerci T., Ucar Z. Z., Erer O. F., Bodur H. A., Bilaceroglu S., ...More

RESPIRATION, vol.75, no.4, pp.402-410, 2008 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 75 Issue: 4
  • Publication Date: 2008
  • Doi Number: 10.1159/000105540
  • Journal Name: RESPIRATION
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.402-410
  • Keywords: chronic obstructive pulmonary disease, hemodynamics, noninvasive ventilation, pressure-controlled ventilation, pressure-support ventilation
  • Dokuz Eylül University Affiliated: Yes

Abstract

Background: Noninvasive ventilation ( NIV) is being increasingly used in hypercapnic chronic obstructive pulmonary disease ( COPD) patients but the most appropriate ventilation mode is still not known. Objectives: The aim of this study was to investigate if assisted pressure-controlled ventilation ( APCV) can be a better alternative to pressure-support ventilation ( PSV) for NIV in COPD patients with acute hypercapnic respiratory failure ( AHRF). Methods: In this prospective randomized study, we evaluated the early effects of noninvasive APCV and PSV in 34 consecutive COPD patients with AHRF. Patients were randomized into 1 of the 2 modes, and respiratory and hemodynamic values were compared before and after 1 h of NIV. Results: Baseline values did not differ between the 2 groups. There were significant improvements in partial arterial carbon dioxide pressure and pH levels in the APCV group when compared with baseline ( p < 0.05). Cardiac output and cardiac index decreased in both groups ( p < 0.05) but more significantly in the PSV group p < 0.0001). The decreases in stroke volume index and increases in arterial oxygen content after NIV were also considerable in both groups ( p < 0.05). Central venous pressure and systemic vascular resistance index values increased notably only after PSV ( p < 0.05). Conclusions: From these data, we deduce that APCV can be a better alternative to PSV for NIV in COPD patients with AHRF owing to its more beneficial physiological effects. Copyright (C) 2007 S. Karger AG, Basel.